Mitochondrial diseases (MDs) are heterogeneous disorders due to impaired respiratory chain function causing defective ATP production. Although the disruption of oxidative phosphorylation is central to the MD pathophysiology, other factors may contribute to these disorders. We investigated the expression and the cellular localization of TNF-α and its receptors, TNFR1 and TNFR2, in muscle biopsies from 15 patients with mitochondrial respiratory chain dysfunction. Our data unambiguously demonstrate that TNF-α is expressed in muscle fibers with abnormal focal accumulations of mitochondria, so-called ragged red fibers, and is delivered to mitochondria where both receptors are localized. Moreover TNF receptors are differentially regulated in patients' muscle in which the expression levels of TNFR1 mRNA are decreased and those of TNFR2 mRNA are increased compared with controls. These findings suggest for the first time that TNF-α could exert a direct effect on mitochondria via its receptors.
Keywords: COX; CPEO; Chronic progressive external ophthalmoplegia; Cytochrome c oxidase; Free radicals; MD; MELAS; MERRF; Mitochondria; Mitochondrial disease; Mitochondrial diseases; Mitochondrial encephalomyopathy with lactic acidosis and stroke-like episodes; Myoclonic epilepsy with ragged red fibers; OXPHOS; Oxidative phosphorylation; Quantitative real-time PCR; ROS; Reactive oxygen species; SDH; Succinate dehydrogenase; TNF receptor type 1; TNF receptor type 2; TNF-α; TNFR1; TNFR2; Tumor necrosis factor-α; qRT-PCR.
Copyright © 2013 Elsevier Inc. All rights reserved.